Short-term treatment of moderate to severe melasma of the face, post-inflammatory hyperpigmentation, and resistant dark spots.
Short-term treatment of moderate to severe melasma of the face, post-inflammatory hyperpigmentation, and resistant dark spots.
Triple combination therapy: Hydroquinone acts as a depigmenting agent by inhibiting tyrosinase; Tretinoin increases epidermal cell turnover and enhances hydroquinone penetration; Mometasone Furoate is a medium-potency corticosteroid that reduces inflammation and prevents localized irritation.
Triple combination therapy: Hydroquinone acts as a depigmenting agent by inhibiting tyrosinase; Tretinoin increases epidermal cell turnover and enhances hydroquinone penetration; Mometasone Furoate is a medium-potency corticosteroid that reduces inflammation and prevents localized irritation.
Apply a pea-sized amount once daily at night to hyperpigmented areas only, at least 30 minutes before bedtime. Do not use continuously for more than 8 weeks.
Apply a pea-sized amount once daily at night to hyperpigmented areas only, at least 30 minutes before bedtime. Do not use continuously for more than 8 weeks.
Gently wash face, pat dry. Rub cream gently into hyperpigmented spots. Mandatory morning application of broad-spectrum sunscreen (SPF 30+).
Pregnancy, viral cutaneous lesions (herpes simplex), hypersensitivity to hydroquinone or retinoids.
Mild erythema, desquamation, skin burning, dryness, telangiectasia, or skin atrophy with prolonged overuse.
Mild erythema, desquamation, skin burning, dryness, telangiectasia, or skin atrophy with prolonged overuse.
Do not use near open cuts or eczematous skin.
Contraindicated in pregnancy due to Tretinoin teratogenic potential. Do not use during breastfeeding.
Store in a refrigerator or cool dry place below 25°C. Keep tube tightly closed. Protect from heat and direct sunlight.
Store in a refrigerator or cool dry place below 25°C. Keep tube tightly closed. Protect from heat and direct sunlight.
Visible lightening of melasma and hyperpigmentation typically begins within 2 to 4 weeks of consistent nightly application alongside strict sunscreen use.
Hydroquinone and Tretinoin make your skin sensitive to sunlight. UV exposure will trigger melanin production, reversing the cream's depigmenting effects.
1. MedEx Bangladesh Hydroquinone Combination Product Guidelines.
2. DGDA Approved Dermatological Formulation Index.
3. Green Darma Product Research Records.